Marion McCourt
EVP Commercial at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
- Rank
- 8971st of 14,644
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
What the $9.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 10,305 | $923.34 | $9.5M | 97.9% | Form 4, Nov 16, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 401(k) Plan | 219 | $923.34 | $202K | 2.1% | Form 4, Nov 16, 2026 |
Share counts are the amounts Marion McCourt reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | REGN | 44 | $952.79 | $42K | View |
| Nov 16, 2026 | Sold | REGN | 59 | $954.46 | $56K | View |
| Nov 16, 2026 | Sold | REGN | 30 | $955.51 | $29K | View |
| Nov 16, 2026 | Sold | REGN | 22 | $956.01 | $21K | View |
| Nov 16, 2026 | Sold | REGN | 44 | $958.47 | $42K | View |
| Nov 16, 2026 | Sold | REGN | 66 | $959.46 | $63K | View |
| Nov 16, 2026 | Sold | REGN | 49 | $960.31 | $47K | View |
| Nov 16, 2026 | Sold | REGN | 59 | $961.36 | $57K | View |
| Nov 16, 2026 | Sold | REGN | 41 | $962.44 | $39K | View |
| Nov 16, 2026 | Sold | REGN | 42 | $963.70 | $40K | View |
| Nov 16, 2026 | Sold | REGN | 21 | $964.69 | $20K | View |
| Nov 16, 2026 | Sold | REGN | 63 | $965.62 | $61K | View |
| Nov 16, 2026 | Sold | REGN | 26 | $971.93 | $25K | View |
| Oct 30, 2026 | Sold | REGN | 1,132 | $869.43 | $984K | View |
| Sep 3, 2026 | Sold | REGN | 1,131 | $857.39 | $970K | View |
| Sep 2, 2026 | Sold | REGN | 1,215 | $850.00 | $1.0M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8968 | Allen Salmasi Chief Executive Officer, Veea. New York, NY | $9.7M |
| 8969 | William A. Koertner Director, MYR Group. Henderson, CO | $9.7M |
| 8970 | Edward R. Muller Director, AeroVironment. Arlington, VA | $9.7M |
| 8971 | Marion McCourt EVP Commercial, Regeneron Pharmaceuticals. Tarrytown, NY | $9.7M |
| 8972 | Denise M. Oleary Director, Medtronic. Fort Worth, TX | $9.7M |
| 8973 | Jay Rembolt VP, Finance, Treasurer & CFO, WD-40. San Diego, CA | $9.7M |
| 8974 | Fulai Wang Insider, Marwynn Holdings. Coto De Caza, CA | $9.7M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.21BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$855MBd. Co-Chair, President & CSO. #312 overall
- P. Roy Vagelos$431MDirector. #529 overall
- Neil E. Stahl$54.7MEVP Research and Development. #2374 overall
- Andrew Murphy$47.3MCo-Chief Scientific Officer. #2647 overall
- Joseph LaRosa$44.4MEVP General Counsel and Secret. #2766 overall
Questions
How much stock does Marion McCourt own?
Marion McCourt holds $9,717,230 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 8971st on the Stock Rich List.
Is this Marion McCourt's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Marion McCourt last buy or sell stock?
The most recent open-market trade on file is a sale of 44 REGN shares on Nov 16, 2026 at $952.79.